180 related articles for article (PubMed ID: 22730654)
1. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
2. Effect of lethal total body irradiation on bone marrow chimerism, acute graft-versus-host disease, and tumor engraftment in mouse models: impact of different radiation techniques using low- and high-energy X-rays.
To NH; Pilon C; Moatti A; Debesset A; Debbi K; Coraggio G; Ksouri W; Massaria V; Cohen JL; Belkacemi Y; Thiolat A
Strahlenther Onkol; 2023 Dec; 199(12):1242-1254. PubMed ID: 36932237
[TBL] [Abstract][Full Text] [Related]
3. Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.
Lim JY; Ryu DB; Lee SE; Park G; Choi EY; Min CK
Mol Cells; 2015 Nov; 38(11):966-74. PubMed ID: 26552489
[TBL] [Abstract][Full Text] [Related]
4. EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation.
Wang W; Ye Y; Du Y; Xu Z; Yuan K; Wang Y; Adzraku SY; Li Y; Xu K; Qiao J; Ju W; Zeng L
Front Immunol; 2022; 13():1019657. PubMed ID: 36591312
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.
Ash S; Stein J; Askenasy N; Yaniv I
Br J Cancer; 2010 Nov; 103(10):1597-605. PubMed ID: 20978501
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and Evaluation Strategy of an
Tian JY; Li PL; Tang J; Xu RX; Yin BF; Wang FY; Li XT; Ning HM; Zhu H; Ding L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):617-624. PubMed ID: 38660875
[TBL] [Abstract][Full Text] [Related]
7. Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.
Weiss L; Weigensberg M; Morecki S; Bar S; Cobbold S; Waldmann H; Slavin S
Cancer Immunol Immunother; 1990; 31(4):236-42. PubMed ID: 2379219
[TBL] [Abstract][Full Text] [Related]
8. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
Capitini CM; Herby S; Milliron M; Anver MR; Mackall CL; Fry TJ
Blood; 2009 May; 113(20):5002-9. PubMed ID: 19258593
[TBL] [Abstract][Full Text] [Related]
11. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.
Maeda Y; Reddy P; Lowler KP; Liu C; Bishop DK; Ferrara JL
Blood; 2005 Jul; 106(2):749-55. PubMed ID: 15797996
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.
Song Q; Wang X; Wu X; Qin H; Li Y; Riggs AD; Martin PJ; Chen YZ; Zeng D
Blood; 2021 Apr; 137(16):2243-2255. PubMed ID: 33511398
[TBL] [Abstract][Full Text] [Related]
13. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of GVHD for allo-bone marrow transplantation recipient by FasL-Fas pathway in an H-2 haplotype disparate mouse combination.
Liu L; Zou P; Hu Z; Zhong Z; Xiao J; Guo R; Xu Z
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):329-33. PubMed ID: 15587391
[TBL] [Abstract][Full Text] [Related]
15. Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cells.
Fricke S; Hilger N; Fricke C; Schönfelder U; Behre G; Ruschpler P; Boldt A; Oelkrug C; Sack U; Emmrich F
Cell Mol Life Sci; 2014 Jun; 71(11):2135-48. PubMed ID: 24067988
[TBL] [Abstract][Full Text] [Related]
16. Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis.
Kanakry JA; Kasamon YL; Bolaños-Meade J; Borrello IM; Brodsky RA; Fuchs EJ; Ghosh N; Gladstone DE; Gocke CD; Huff CA; Kanakry CG; Luznik L; Matsui W; Mogri HJ; Swinnen LJ; Symons HJ; Jones RJ; Ambinder RF
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1514-7. PubMed ID: 23871780
[TBL] [Abstract][Full Text] [Related]
17. Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.
Zhu J; Wang Y; Li J; Das PK; Zhang H; Passang T; Li JM; Nagy T; Gandhi K; Ravindranathan S; Giver CR; Hassan M; Li Y; Antonova AU; Wang S; Roback JD; Waller EK
Blood; 2022 Sep; 140(12):1431-1447. PubMed ID: 35443019
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
Nguyen H; Alawieh A; Bastian D; Kuril S; Dai M; Daenthanasanmak A; Zhang M; Iamsawat S; Schutt SD; Wu Y; Sleiman MM; Shetty A; Atkinson C; Sun S; Varela JC; Tomlinson S; Yu XZ
Clin Cancer Res; 2020 Jul; 26(13):3481-3490. PubMed ID: 31919135
[TBL] [Abstract][Full Text] [Related]
19. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.
Wang D; Yu Y; Haarberg K; Fu J; Kaosaard K; Nagaraj S; Anasetti C; Gabrilovich D; Yu XZ
Biol Blood Marrow Transplant; 2013 May; 19(5):692-702. PubMed ID: 23376089
[TBL] [Abstract][Full Text] [Related]
20. Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Aycox PG; Stephens C; McCue LD; Champlin RE; Marini FC
Exp Hematol; 2007 May; 35(5):842-53. PubMed ID: 17577932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]